3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Multiple Myeloma
107
Precursor Cell Lymphoblastic Leukemia-Lymphoma
40
Recurrence
20
Leukemia
18
Burkitt Lymphoma
18
Lymphoma
17
Neoplasms, Plasma Cell
13
Lymphoma, Non-Hodgkin
13
Nausea
12
Lymphoma, Mantle-Cell
12
Vomiting
11
Waldenstrom Macroglobulinemia
10
Breast Neoplasms
10
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
9
Neoplasms
9
Lymphoma, Follicular
9
Immunoglobulin Light-chain Amyloidosis
8
Lymphoma, B-Cell, Marginal Zone
7
Hodgkin Disease
7
Amyloidosis
7
Smoldering Multiple Myeloma
6
Lymphoma, Large B-Cell, Diffuse
6
Leukemia, Myeloid, Acute
6
Leukemia, Lymphocytic, Chronic, B-Cell
6
Prostatic Neoplasms
5
Leukemia, Biphenotypic, Acute
5
Hematologic Neoplasms
5
Sezary Syndrome
4
Mycosis Fungoides
4
Lymphoma, T-Cell, Cutaneous
4
Interventions
Irinotecan
3
pembrolizumab
2
Oxaliplatin
2
Leucovorin
2
Fluorouracil
2
trifluridine tipiracil drug combination
1
pralsetinib
1
napabucasin
1
alectinib
1
S-1 plus cisplatin
1
Levoleucovorin
1
KRN-330
1
Indocyanine Green
1
Imatinib Mesylate
1
Fluorescein
1
Docetaxel
1
Cyclophosphamide
1
Calcium Dobesilate
1
Bupivacaine
1
Bevacizumab
1
Ascorbic Acid
1
5,10-methylenetetrahydrofolic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Gastrointestinal Diseases
×
Calcium Dobesilate
×
Clear all
NCT03723447
2021-02-17
TINGLE
Cedars-Sinai Medical Center
Phase 4
Completed
102 enrolled
9 charts